{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:14Z","timestamp":1793395634300,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Lipocalin-2 (LCN2), a pleiotropic protein implicated in tumorigenesis and cancer progression, has been associated with multiple malignancies. However, its precise role in NSCLC and the underlying molecular mechanisms remain incompletely understood. This study aimed to elucidate the function of LCN2 in NSCLC, with a particular focus on its involvement in the Janus kinase 2\/signal transducer and activator of transcription 3 (JAK2\/STAT3) signaling pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>LCN2 expression in NSCLC tissues was comprehensively analyzed using bioinformatics tools, including the Universal Analysis of Cancer (UALCAN), The Cancer Genome Atlas (TCGA), UCSC-XENA, and Gene Expression Omnibus (GEO) databases. Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting were employed to assess LCN2 expression levels in NSCLC cell lines. The functional impact of LCN2 on NSCLC cells, including proliferation, apoptosis, and metastasis, were assessed through a series of in vitro assays, such as Cell Counting Kit-8 (CCK-8), EdU, wound healing, and transwell migration and invasion assays. An in vivo xenograft model was established to investigate the effects of LCN2 on tumor growth and metastasis. Additionally, the involvement of the JAK2\/STAT3 signaling pathway was examined using western blotting and pharmacological inhibition with AG490.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>LCN2 was significantly upregulated in NSCLC tissues and cell lines, and its elevated expression correlated with poor prognosis. Functional analyses demonstrated that LCN2 knockdown suppressed NSCLC cell proliferation, migration, and invasion while promoting apoptosis. Mechanistically, LCN2 was found to activate the JAK2\/STAT3 pathway by interacting with SOCS3, and pharmacological blockade of this pathway effectively abrogated the oncogenic effects of LCN2 overexpression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study identifies LCN2 as a potential oncogene in NSCLC, driving tumor progression through activation of the JAK2\/STAT3 signaling pathway. These findings suggest that targeting LCN2 or its downstream signaling components may represent a promising therapeutic strategy for NSCLC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12967-025-06418-1","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:42:38Z","timestamp":1744292558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Lipocalin-2 promotes NSCLC progression by activating the JAK2\/STAT3 signaling pathway"],"prefix":"10.1186","volume":"23","author":[{"given":"Jinjin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"10299","key":"6418_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354.","journal-title":"Lancet"},{"issue":"9","key":"6418_CR2","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.7150\/thno.72803","volume":"12","author":"X Yin","year":"2022","unstructured":"Yin X, Cui Y, Kim RS, Stiles WR, Park SH, Wang H, Ma L, Chen L, Baek Y, Kashiwagi S, et al. Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy. Theranostics. 2022;12(9):4147\u201362.","journal-title":"Theranostics"},{"issue":"1","key":"6418_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-021-01469-6","volume":"20","author":"Y He","year":"2021","unstructured":"He Y, Jiang X, Duan L, Xiong Q, Yuan Y, Liu P, Jiang L, Shen Q, Zhao S, Yang C, Chen Y. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. Mol Cancer. 2021;20(1):156.","journal-title":"Mol Cancer"},{"key":"6418_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu Rev Nutr. 2017;37:103\u201330.","journal-title":"Annu Rev Nutr"},{"issue":"4","key":"6418_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.7150\/ijbs.79915","volume":"19","author":"HS An","year":"2023","unstructured":"An HS, Yoo JW, Jeong JH, Heo M, Hwang SH, Jang HM, Jeong EA, Lee J, Shin HJ, Kim KE, et al. Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation. Int J Biol Sci. 2023;19(4):1163\u201377.","journal-title":"Int J Biol Sci"},{"key":"6418_CR6","doi-asserted-by":"crossref","unstructured":"Sun WY, Bai B, Luo C, Yang K, Li D, Wu D, Feletou M, Villeneuve N, Zhou Y, Yang J et al. Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury. JCI Insight. 2018; 3(17).","DOI":"10.1172\/jci.insight.120196"},{"issue":"6501","key":"6418_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","volume":"369","author":"Y Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, Saadeh F, Nikishina K, Bale T, Iacobuzio-Donahue C, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369(6501):276\u201382.","journal-title":"Science"},{"key":"6418_CR8","doi-asserted-by":"publisher","first-page":"118492","DOI":"10.1016\/j.lfs.2020.118492","volume":"262","author":"P Hao","year":"2020","unstructured":"Hao P, Li H, Wu A, Zhang J, Wang C, Xian X, Ren Q, Hao N, Wang Y, Yue F, Cui H. Lipocalin2 promotes cell proliferation and migration in ovarian cancer through activation of the ERK\/GSK3beta\/beta-catenin signaling pathway. Life Sci. 2020;262:118492.","journal-title":"Life Sci"},{"issue":"1","key":"6418_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41467-020-20733-9","volume":"12","author":"A Tyagi","year":"2021","unstructured":"Tyagi A, Sharma S, Wu K, Wu SY, Xing F, Liu Y, Zhao D, Deshpande RP, D\u2019Agostino RB Jr., Watabe K. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12(1):474.","journal-title":"Nat Commun"},{"issue":"10","key":"6418_CR10","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1158\/0008-5472.CAN-16-1986","volume":"77","author":"SB Gomez-Chou","year":"2017","unstructured":"Gomez-Chou SB, Swidnicka-Siergiejko AK, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, et al. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. Cancer Res. 2017;77(10):2647\u201360.","journal-title":"Cancer Res"},{"issue":"1","key":"6418_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-023-02618-z","volume":"42","author":"Z Huang","year":"2023","unstructured":"Huang Z, Rui X, Yi C, Chen Y, Chen R, Liang Y, Wang Y, Yao W, Xu X, Huang Z. Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling. J Exp Clin Cancer Res. 2023;42(1):60.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"6418_CR12","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.26467","volume":"58","author":"YP Wang","year":"2013","unstructured":"Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)\/Lcn2\/Twist1 pathway. Hepatology. 2013;58(4):1349\u201361.","journal-title":"Hepatology"},{"issue":"5","key":"6418_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s10120-022-01305-w","volume":"25","author":"S Nishimura","year":"2022","unstructured":"Nishimura S, Yamamoto Y, Sugimoto A, Kushiyama S, Togano S, Kuroda K, Okuno T, Kasashima H, Ohira M, Maeda K, Yashiro M. Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer. Gastric Cancer. 2022;25(5):850\u201361.","journal-title":"Gastric Cancer"},{"issue":"1","key":"6418_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang D, Li X, Jiao D, Cai Y, Qian L, Shen Y, Lu Y, Zhou Y, Fu B, Sun R, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J Hematol Oncol. 2023;16(1):30.","journal-title":"J Hematol Oncol"},{"key":"6418_CR15","doi-asserted-by":"crossref","unstructured":"Finnicum CT, Rahal Z, Hassane M, Treekitkarnmongkol W, Sinjab A, Morris R, Liu Y, Tang EL, Viet S, Petersen JL et al. Pathogenesis of Tobacco-Associated lung adenocarcinoma is closely coupled with changes in the gut and lung microbiomes. Int J Mol Sci. 2022; 23(18).","DOI":"10.3390\/ijms231810930"},{"key":"6418_CR16","doi-asserted-by":"publisher","first-page":"106359","DOI":"10.1016\/j.phrs.2022.106359","volume":"183","author":"M Benucci","year":"2022","unstructured":"Benucci M, Damiani A, Infantino M, Manfredi M, Lari B, Grossi V, Gobbi FL, Sarzi-Puttini P. Cardiovascular safety, cancer and Jak-inhibitors: differences to be highlighted. Pharmacol Res. 2022;183:106359.","journal-title":"Pharmacol Res"},{"issue":"1","key":"6418_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-020-01769-7","volume":"39","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Song J, Tang B, Fang S, Zhang D, Zheng L, Wu F, Gao Y, Chen C, Hu X, et al. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res. 2020;39(1):259.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"6418_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41419-024-06495-y","volume":"15","author":"X Jin","year":"2024","unstructured":"Jin X, Shang B, Wang J, Sun J, Li J, Liang B, Wang X, Su L, You W, Jiang S. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2\/STAT3 signaling via transactivation of IL-6ST and IL-6 genes. Cell Death Dis. 2024;15(2):148.","journal-title":"Cell Death Dis"},{"issue":"Pt 1","key":"6418_CR19","doi-asserted-by":"publisher","first-page":"136545","DOI":"10.1016\/j.chemosphere.2022.136545","volume":"312","author":"Y Wang","year":"2023","unstructured":"Wang Y, Kang J, Wang R, Ramezani K, Bonakdar M, Moghimi N, Salimi M, Yao Y, Wang K. Bisphenol A interacts with DLGAP5 and regulates IL-6\/JAK2\/STAT3 signaling pathway to promote tumorigenesis and progression of osteosarcoma. Chemosphere. 2023;312(Pt 1):136545.","journal-title":"Chemosphere"},{"key":"6418_CR20","doi-asserted-by":"publisher","first-page":"119547","DOI":"10.1016\/j.lfs.2021.119547","volume":"278","author":"Z Geng","year":"2021","unstructured":"Geng Z, Shan X, Lian S, Wang J, Wu R. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits beta-casein synthesis in bovine mammary epithelial cells. Life Sci. 2021;278:119547.","journal-title":"Life Sci"},{"issue":"5","key":"6418_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","volume":"40","author":"GA Durham","year":"2019","unstructured":"Durham GA, Williams JJL, Nasim MT, Palmer TM. Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol Sci. 2019;40(5):298\u2013308.","journal-title":"Trends Pharmacol Sci"},{"issue":"42","key":"6418_CR22","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1038\/s41388-020-01454-1","volume":"39","author":"D Doheny","year":"2020","unstructured":"Doheny D, Sirkisoon S, Carpenter RL, Aguayo NR, Regua AT, Anguelov M, Manore SG, Arrigo A, Jalboush SA, Wong GL, et al. Combined Inhibition of JAK2-STAT3 and SMO-GLI1\/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene. 2020;39(42):6589\u2013605.","journal-title":"Oncogene"},{"issue":"14","key":"6418_CR23","doi-asserted-by":"publisher","first-page":"e34115","DOI":"10.1016\/j.heliyon.2024.e34115","volume":"10","author":"X Wei","year":"2024","unstructured":"Wei X, Song J, Rao Q, Huang Y, Liu Q, Song J, Liang W, Feng S, Yan C, Li Y. TMJ-105, an extract of carpesium cernuum, induced G2\/M phase arrest and apoptosis via the JAK2\/STAT3 axis and MAPKs signaling pathway in leukemia HEL cells. Heliyon. 2024;10(14):e34115.","journal-title":"Heliyon"},{"issue":"5","key":"6418_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.7150\/ijbs.77979","volume":"19","author":"C Zhou","year":"2023","unstructured":"Zhou C, Yu T, Zhu R, Lu J, Ouyang X, Zhang Z, Chen Q, Li J, Cui J, Jiang F, et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19(5):1471\u201389.","journal-title":"Int J Biol Sci"},{"key":"6418_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.omto.2019.08.001","volume":"14","author":"Z Li","year":"2019","unstructured":"Li Z, Zeng C, Nong Q, Long F, Liu J, Mu Z, Chen B, Wu D, Wu H. Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 derived from Non-Small-Cell lung cancer cells promotes angiogenesis via TGF-beta signal pathway. Mol Ther Oncolytics. 2019;14:313\u201322.","journal-title":"Mol Ther Oncolytics"},{"key":"6418_CR26","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.molmet.2022.101612","volume":"66","author":"M Lemecha","year":"2022","unstructured":"Lemecha M, Chalise JP, Takamuku Y, Zhang G, Yamakawa T, Larson G, Itakura K. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia. Mol Metab. 2022;66:101612.","journal-title":"Mol Metab"},{"issue":"2","key":"6418_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41419-021-03512-2","volume":"12","author":"X Wen","year":"2021","unstructured":"Wen X, Su B, Gao M, Chen J, Zhou D, You H, Li N, Chang S, Cheng X, Qian C, et al. Obesity-associated up-regulation of Lipocalin 2 protects gastric mucosa cells from apoptotic cell death by reducing Endoplasmic reticulum stress. Cell Death Dis. 2021;12(2):221.","journal-title":"Cell Death Dis"},{"key":"6418_CR28","doi-asserted-by":"publisher","first-page":"116091","DOI":"10.1016\/j.biopha.2023.116091","volume":"171","author":"Y Bao","year":"2024","unstructured":"Bao Y, Yan Z, Shi N, Tian X, Li J, Li T, Cheng X, Lv J. LCN2: versatile players in breast cancer. Biomed Pharmacother. 2024;171:116091.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"6418_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/abbs\/gmv085","volume":"47","author":"B Song","year":"2015","unstructured":"Song B, Zhang H, Jiang L, Chi Y, Tian J, Du W, Yu B, Han Z. Down-regulation of Lipocalin 2 suppresses the growth of human lung adenocarcinoma through oxidative stress involving Nrf2\/HO-1 signaling. Acta Biochim Biophys Sin (Shanghai). 2015;47(10):805\u201314.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"6418_CR30","doi-asserted-by":"publisher","first-page":"148026","DOI":"10.1016\/j.gene.2023.148026","volume":"894","author":"Z Pan","year":"2024","unstructured":"Pan Z, Li B, Lu P, Rong G, Wang X. Inhibiting LCN2 can suppress the development of NSCLC by promoting ferroptosis. Gene. 2024;894:148026.","journal-title":"Gene"},{"issue":"1","key":"6418_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1164\/rccm.202004-1079OC","volume":"203","author":"W Treekitkarnmongkol","year":"2021","unstructured":"Treekitkarnmongkol W, Hassane M, Sinjab A, Chang K, Hara K, Rahal Z, Zhang J, Lu W, Sivakumar S, McDowell TL, et al. Augmented Lipocalin-2 is associated with chronic obstructive pulmonary disease and counteracts lung adenocarcinoma development. Am J Respir Crit Care Med. 2021;203(1):90\u2013101.","journal-title":"Am J Respir Crit Care Med"},{"key":"6418_CR32","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/JIR.S353489","volume":"15","author":"T Mengie Ayele","year":"2022","unstructured":"Mengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale Kassie A, Chekol Abebe E. Role of JAK2\/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: A systemic review. J Inflamm Res. 2022;15:1349\u201364.","journal-title":"J Inflamm Res"},{"issue":"3","key":"6418_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-022-04747-3","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Zhang H, Zhou H, Jiao T, Feng M, Na F, Sun M, Zhao M, Xue L, Xu L. RBMS1 promotes gastric cancer metastasis through autocrine IL-6\/JAK2\/STAT3 signaling. Cell Death Dis. 2022;13(3):287.","journal-title":"Cell Death Dis"},{"issue":"6","key":"6418_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.7150\/ijms.70733","volume":"19","author":"W Liu","year":"2022","unstructured":"Liu W, Wang X, Wang L, Mei Y, Yun Y, Yao X, Chen Q, Zhou J, Kou B. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2\/STAT3 signaling. Int J Med Sci. 2022;19(6):965\u201374.","journal-title":"Int J Med Sci"},{"issue":"5","key":"6418_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-022-04890-x","volume":"13","author":"LN Wang","year":"2022","unstructured":"Wang LN, Zhang ZT, Wang L, Wei HX, Zhang T, Zhang LM, Lin H, Zhang H, Wang SQ. TGF-beta1\/SH2B3 axis regulates Anoikis resistance and EMT of lung cancer cells by modulating JAK2\/STAT3 and SHP2\/Grb2 signaling pathways. Cell Death Dis. 2022;13(5):472.","journal-title":"Cell Death Dis"},{"key":"6418_CR36","doi-asserted-by":"crossref","unstructured":"Kopalli SR, Annamneedi VP, Koppula S. Potential natural biomolecules targeting JAK\/STAT\/SOCS signaling in the management of atopic dermatitis. Molecules. 2022; 27(14).","DOI":"10.3390\/molecules27144660"},{"issue":"3","key":"6418_CR37","first-page":"e24053","volume":"2","author":"K Inagaki-Ohara","year":"2013","unstructured":"Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. SOCS, inflammation, and cancer. JAKSTAT. 2013;2(3):e24053.","journal-title":"JAKSTAT"},{"issue":"4","key":"6418_CR38","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/bjh.18694","volume":"201","author":"A Lahera","year":"2023","unstructured":"Lahera A, Lopez-Nieva P, Alarcon H, Marin-Rubio JL, Cobos-Fernandez MA, Fernandez-Navarro P, Fernandez AF, Vela-Martin L, Sastre I, Ruiz-Garcia S, et al. SOCS3 deregulation contributes to aberrant activation of the JAK\/STAT pathway in precursor T-cell neoplasms. Br J Haematol. 2023;201(4):718\u201324.","journal-title":"Br J Haematol"},{"issue":"4","key":"6418_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nsmb.2519","volume":"20","author":"NJ Kershaw","year":"2013","unstructured":"Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, Lucet IS, Nicola NA, Babon JJ. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase Inhibition. Nat Struct Mol Biol. 2013;20(4):469\u201376.","journal-title":"Nat Struct Mol Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06418-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06418-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06418-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:42:43Z","timestamp":1744292563000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06418-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6418"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06418-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research underwent rigorous review and received approval from the Clinical Medical Research Ethics Committee of The First Affiliated Hospital of Anhui Medical University, as well as from Anhui Medical University\u2019s Animal Experimental Committee (Hefei, China). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}